Inhibikase Therapeutics, Inc. (IKT) vs Invivyd, Inc. (IVVD)
A side-by-side comparison of Inhibikase Therapeutics, Inc. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IKT
Inhibikase Therapeutics, Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
IVVD
Invivyd, Inc.
$0.81HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — IKT vs IVVD
growth of $100 · dividends reinvested · last 5yIKT -85.5% (-32.0%/yr)IVVD -96.0% (-47.4%/yr)IKT compounded faster over this window
IKT IVVD
IKT vs IVVD: by the numbers
- •IKT is the larger company ($265M vs $239M market cap).
- •Both run net losses; IKT's is the smaller (0.00% vs -183.90% net margin).
Metrics side by side
Valuation
| Metric | IKT | IVVD |
|---|---|---|
| P/S ratio | N/A | 4.10 |
| P/B ratio | 1.73 | 1.32 |
Profitability
| Metric | IKT | IVVD |
|---|---|---|
| Gross margin | 0.00% | 91.35% |
| Operating margin | 0.00% | -103.99% |
| Net margin | 0.00% | -183.90% |
| ROE | -39.55% | -59.27% |
| ROIC | -42.92% | -59.90% |
Growth (annualized)
| Metric | IKT | IVVD |
|---|---|---|
| Total return CAGR (5Y) | -29.10% | -51.69% |
Frequently asked
- How have IKT and IVVD total returns compared?
- Over the past 5 years, IKT delivered -29.10% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.